Medicus Pharma Ltd. Common Stock Stock Analysis & AI Score
Medicus Pharma Ltd. Common Stock (MDCX) has an ST Score of 42.1 (C), driven by its Forecast (A) and held back by its Momentum (D). Analysts rate it Buy with a $1.00 price target (+529.7% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Medicus Pharma Ltd. Common Stock (MDCX) has an ST Score of 42.1 (C), driven by its Forecast (A) and held back by its Momentum (D). Analysts rate it Buy with a $1.00 price target (+529.7% upside).
- Strongest
- ForecastA
- Weakest
- MomentumD
All factor grades
- ForecastA
- GrowthB
- ValuationC
- Financial StrengthC
- ProfitabilityC-
- MomentumD
- Piotroski2/9
Contact
MDCX stock: frequently asked questions
What is MDCX's ST Score?
Medicus Pharma Ltd. Common Stock (MDCX) has an ST Score of 42.1 (C), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is MDCX a buy, hold, or sell?
Analysts rate MDCX a Buy, with a price target of $1.00 (+529.7% vs the current price). Our ST Score grades it C (42.1/100). The ST Score is a data-driven signal, not a recommendation.
What are MDCX's factor grades?
Valuation C, Profitability C-, Financial Strength C, Momentum D, Growth B, Forecast A.
What is MDCX's valuation grade?
Medicus Pharma Ltd. Common Stock (MDCX) earns a valuation grade of C, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is MDCX's growth grade?
Medicus Pharma Ltd. Common Stock (MDCX) earns a growth grade of B, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is MDCX's profitability grade?
Medicus Pharma Ltd. Common Stock (MDCX) earns a profitability grade of C-, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is MDCX's financial strength grade?
Medicus Pharma Ltd. Common Stock (MDCX) earns a financial strength grade of C, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for MDCX?
The average analyst price target for Medicus Pharma Ltd. Common Stock (MDCX) is $1.00 from 2 analysts, which is +529.7% versus the recent price of $0.16.
What is MDCX's Piotroski score?
Medicus Pharma Ltd. Common Stock (MDCX) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.